We are live on ! Find out more
CAH icon

Cardinal Health

245.56 USD
-0.89
0.36%
At close Updated Oct 28, 12:37 PM EDT
1 day
-0.36%
5 days
-4.9%
1 month
11.47%
3 months
5.61%
6 months
19.43%
Year to date
19.37%
1 year
50.84%
5 years
414.59%
10 years
263.79%
 

About: Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Employees: 63,900

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 55.6%
Neutral 37%
Negative 7.4%
Negative
Zacks Investment Research
17 hours ago
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Cardinal Health (CAH) reached $246.45 at the closing of the latest trading day, reflecting a -2.02% change compared to its last close.
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Neutral
Seeking Alpha
5 days ago
The Dividend Aristocrats Ranked By Quality Scores (October 2026)
I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, highlight 12 undervalued and 18 fairly valued Aristocrats, with 39 currently overvalued. Investment candidates vary by style: ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; CAT and GWW for past performance.
The Dividend Aristocrats Ranked By Quality Scores (October 2026)
Neutral
Zacks Investment Research
7 days ago
Cardinal Health (CAH) Laps the Stock Market: Here's Why
Cardinal Health (CAH) concluded the recent trading session at $257.55, signifying a +1.94% move from its prior day's close.
Cardinal Health (CAH) Laps the Stock Market: Here's Why
Positive
Market Watch
9 days ago
Big tech is wobbling. Goldman Sachs says it's time to buy these 23 unloved stocks instead.
Goldman Sachs says consumer-facing laggard stocks are the best way forward as earnings growth is set to slow next year and big tech stocks struggle.
Big tech is wobbling. Goldman Sachs says it's time to buy these 23 unloved stocks instead.
Neutral
Zacks Investment Research
12 days ago
Cardinal Health (CAH) Laps the Stock Market: Here's Why
Cardinal Health (CAH) closed at $253.71 in the latest trading session, marking a +2.41% move from the prior day.
Cardinal Health (CAH) Laps the Stock Market: Here's Why
Positive
Zacks Investment Research
12 days ago
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
Positive
Zacks Investment Research
15 days ago
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Negative
Zacks Investment Research
15 days ago
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Positive
Zacks Investment Research
15 days ago
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Positive
Zacks Investment Research
22 days ago
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
Price charts implemented using Lightweight Charts™